Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine

Eye

Volumn 10, Issue 4, 1996, Pages 413-421

  Seal, David ^a   Hay, John ^a   Kirkness, Colin ^a   Morrell, Andrew ^b   Booth, Adam ^b   Tullo, Andrew ^c   Ridgway, Alan ^c   Armstrong, Malcolm ^c  

^a WESTERN INFIRMARY   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; DISINFECTANT AGENT; PROPAMIDINE; STEROID;

ACANTHAMOEBA; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CORNEA STROMA; CYST; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; HUMAN; KERATITIS; MALE; MULTICENTER STUDY; PARASITE CULTIVATION; SCAR; TOPICAL DRUG ADMINISTRATION; TROPHOZOITE;

EID: 0029795587     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1996.92     Document Type: Article

References (48)

1. Wright P, Warhurst D, Jones BR. Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 1985;69:778-82.
2. Larkin DFP, Kilvington S, Dart JKG. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 1992;99:185-91.
3. Varga JH, Wolf TC, Jensen HG, Parmley VC, Rowsey JJ. Combined treatment of Acanthamoeba keratitis with propamidine, neomycin and polyhexamethylene biguanide. Am J Ophthalmol 1993;115:466-70.
4. Hay J, Kirkness CM, Seal DV, Wright P. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy. Eye 1994;8: 555-63.
5. Elder MJ, Kilvington S, Dart JKG. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1994;35:1059-64.
6. Tirado-Angel J, Gabriel MM, Wilson L, Ahearn R. Effects of polyhexamethylene biguanide and chlorhexidine digluconate on 4 species of free-living Acanthamoeba in vitro. Invest Ophthalmol Vis Sci 1995;36(4, Suppl):S327.
7. Seal DV, Hay J, Kirkness CM. Chlorhexidine or polyhexamethylene biguanide for Acanthamoeba keratitis. Lancet 1995;345:136.
8. Booth A, Morrell AJ. Acanthamoeba keratitis. Eye 1994;8:719-20.
9. Armstrong M. The laboratory investigation of infective keratitis. Br J Biomed Sci 1994;51:65-72.
10. Hay J, Kinnear F, Kirkness CM, Seal DV. Acanthamoeba keratitis: laboratory diagnosis, characterisation of protozoa and treatment. Scottish Centre Infect Environ Health 1995;29(95/17):90-1.
11. Seal DV, Hay J, Devonshire P, Kirkness CM. Acanthamoeba and contact lens disinfection: should chlorine be discontinued? Br J Ophthalmol 1993;77:128.
12. Sarwar N, Griffith GAP, Loudon K, Tullo AB, Efron E. Acanthamoeba keratitis associated with disposable hydrogel contact lenses disinfected daily with chlorine-based care system. J Br Contact Lens Assoc 1993;16: 15-8.
13. Radford CF, Bacon AS, Dart JKG, Minassian DC. Risk factors for Acanthamoeba keratitis in contact lens users: a case-control study. BMJ 1995;310:1567-70.
14. Seal DV, Hay J. Contact lens disinfection and Acanthamoeba: problems and practicalities. Pharm J 1992;248:717-9.
15. Hay J, Seal DV, Connor R, Simmons PA, Tomlinson A. Disinfection and sonication: effect on association of Acanthamoeba cysts with an ionic, high water content contact lens. J Br Contact Lens Assoc 1995:18:5-8.
16. Bacon AS, Dart JKG, Ficker LA, Matheson MM, Wright P. Acanthamoeba keratitis: the value of early diagnosis. Ophthalmology 1993;100:1238-43.
17. Ficker LA, Kirkness C, Wright P. Prognosis for keratoplasty in Acanthamoeba keratitis. Ophthalmology 1993;100:105-10.
18. Ficker L, Seal DV, Warhurst D, Wright P. Acanthamoeba keratitis: resistance to medical therapy. Eye 1990;4:835-8.
19. Gray TB, Gross KA, Cursons RTM, Shewan JF. Acanthamoeba keratitis: a sobering case and a promising new treatment. Aust NZ J Ophthalmol 1994;22: 73-6.
20. Brasseur G, Favennec L, Perrine D, Chenu JP, Brasseur P. Successful treatment of Acanthamoeba keratitis by hexamidine. Cornea 1994;13:456-62.
21. Perrine D, Chenu JP, Georges P, Lancelot JC, Saturnino C, Robba M. Amoebicidal efficiencies of various diamidines against two strains of Acanthamoeba polyphaga. Antimicrob Ag Chemother 1995;39:339-42.
22. Pearlman E, Lass JH. Keratitis due to onchocerciasis. Ophthalmol Clin North Am 1994;7:641-8.
23. Hendricks RL, Tang Q. Cellular immunity and the eye. In: Pepose JS, Holland GN. Wilhelmus KR, editors. Ocular infection and immunity. St Louis: Mosby-Year Book, 1996:71-95.
24. Dougherty PJ, Binder PS, Mondino BJ, Glasgow BJ. Acanthamoeba sclerokeratitis. Am J Ophthalmol 1994;117:475-9.
25. Pineda R, Dohlman CH. The role of steroids in the management of Acanthamoeba keratitis, fungal keratitis and epidemic keratoconjunctivitis. Int Ophthalmol Clin 1994;34:19-31.
26. D'Aversa G, Stern GA, Driebe T. Diagnosis and successful medical treatment of Acanthamoeba keratitis. Arch Ophthalmol 1995;113:1120-3.
27. Roed A. Effects of chlorhexidine on the isolated rat phrenic nerve-diaphragm preparation. Pharmacol Toxicol 1994;74:10-6.
28. Zampatti O, Roques Ch, Michel G. An in vitro mouth model to test anti-plaque agents: preliminary studies using a toothpaste containing chlorhexidine. Caries Res 1994;28:35-42.
29. Pucher JJ, Daniel JC. The effects of chlorhexidine digluconate on human fibroblasts in vitro. J Periodontol 1992;63:526-32.
30. Celdran A, Inarrea P, Fernandez J, Larrocha C, Madero R. Neutrophil dynamics in abdominal cavity of peritonitic rats treated with antiseptics. Int Surg 1993;78:354-6.
31. Severyns AM, Lejeune A, Rocoux G, Lejeune G. Non-toxic antiseptic irrigation with chlorhexidine in experimental revascularization in the rat. J Hosp Inf 1991;17: 197-206.
32. Archer H, Barnett S, Irving S, Middleton K, Seal DV. A controlled model of moist wound healing: comparison between semi-permeable film, antiseptics and sugar paste. J Exp Pathol 1990;71:155-70.
33. Niedner R. Schopf E. Inhibition of wound healing by antiseptics. Br J Dermatol 1986;115(Suppl 31): 41-4.
34. Brennan SS, Foster ME, Leaper DJ. Antiseptic toxicity in wounds healing by secondary intention. J Hosp Inf 1986;8:263-7.
35. Bowes Hamill M, Osato MS, Wilhelmus KR. Experimental evaluation of chlorhexidine gluconate for ocular antiseptics. Antimicrob Ag Chemother 1984;26:793-6.
36. Platt J, Bucknall RA. An experimental evaluation of antiseptic wound irrigation. J Hosp Inf 1984;5:181-8.
37. Green K, Livingston V, Bowman K, Hull DS. Chlorhexidine effects on corneal epithelium and endothelium. Arch Ophthalmol 1980;98:1273-8.
38. Browne RK, Anderson AN, Charvez BW, Azzarello RJ. Ophthalmic response to chlorhexidine digluconate in rabbits. Toxicol Appl Pharmacol 1975;32:621-7.
39. Hamed LM, Ellis FD, Boudreault G, Wilson FM, Helveston EM. Hibiclens keratitis. Am J Ophthalmol 1987;104:50-6.
40. Albandar JM, Gjermo P, Preus HR. Chlorhexidine use after two decades of over-the-counter availability. J Periodontol 1994;65:109-12.
41. Jenkins S, Addy M, Newcombe RG. Dose response of chlorhexidine against plaque and comparison with triclosan. J Clin Periodontol 1994;21:250-5.
42. Emilson CG. Potential efficacy of chlorhexidine against Mutans streptococci and human dental caries. J Dent Res 1994;73:682-91.
43. Creel D. Inappropriate use of albino animals as models in research. Pharmacol Biochem Behav 1980;12: 969-77.
44. Bicknell PG. Sensorineural deafness following myringoplasty operations. J Laryngol Otol 1971;85:957-61.
45. Mills RA, Wilhelmus KR, Osato MS, Pyron M. Polyhexamethylene biguanide in the treatment of Acanthamoeba keratitis. Aust NZ J Ophthalmol 1993;21:277-8.
46. Mathers WD, Sutphin JE, Folberg R, Meier P, Wenzel RP, Elgin R. Outbreak of keratitis presumed to be caused by Acanthamoeba. Am J Ophthalmol 1996;121: 129-42.
47. Kamel AGM, Norazah A. First case of Acanthamoeba keratitis in Malaysia. Trans R Soc Trop Med Hyg 1995;89:652.
48. Seal DV, Hay J, Kirkness CM. Acanthamoeba keratitis and contact lens wear: the need for a global strategy for prevention of corneal infection. Community Eye Health 1995;8:4-6.